Multifocal paragangliomas depicted by I-123 metaiodobenzylguanidine

被引:2
|
作者
Jacobsson, H [1 ]
Svartberg, J
Wallin, G
Grimelius, L
Larsson, SA
机构
[1] Karolinska Hosp, Dept Diagnost Radiol, SE-17176 Stockholm, Sweden
[2] Karolinska Hosp, Dept Endocrinol & Diabetol, SE-17176 Stockholm, Sweden
[3] Karolinska Hosp, Dept Surg, SE-17176 Stockholm, Sweden
[4] Karolinska Hosp, Dept Pathol, SE-17176 Stockholm, Sweden
[5] Karolinska Hosp, Dept Hosp Phys, SE-17176 Stockholm, Sweden
关键词
I-123; MIBG; multiple tumors; paragangliomas;
D O I
10.1097/00003072-199811000-00019
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A 23-year-old man was hospitalized because of hypertension, heart palpitations, headache, and sweating. Clinical investigation revealed a highly increased urinary excretion of norepinephrine. Radionuclide imaging with I-123 metaiodobenzylguanidine showed a series of hot spots at the lower portion of the left sympathetic chain. The radiotracer bears a structural resemblance to nor-epinephrine. It accumulates in neurosecretory storage granules of chromaffin cells and is used to localize of neural crest tumors. At surgery, four separate tumor masses were removed. The diagnosis was multifocal paragangliomas. One year after surgery, the patient is clinically well and the urinary catecholamines are normal.
引用
收藏
页码:783 / 783
页数:1
相关论文
共 50 条
  • [1] UPTAKE OF I-123 METAIODOBENZYLGUANIDINE BY PHEOCHROMOCYTOMAS, PARAGANGLIOMAS, AND NEUROBLASTOMAS - A HISTOPATHOLOGICAL COMPARISON
    BOMANJI, J
    LEVISON, DA
    FLATMAN, WD
    HORNE, T
    BOULOUX, PMG
    ROSS, G
    BRITTON, KE
    BESSER, GM
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1987, 28 (06) : 973 - 978
  • [2] THE KINETICS OF I-123 METAIODOBENZYLGUANIDINE (I-123) IN ADRENERGIC-NEURONS
    SISSON, JC
    GLOWNIAK, JV
    SHAPIRO, B
    MEYERS, L
    MALLETTE, S
    MANGNER, T
    BEIERWALTES, WH
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1985, 11 (2-3): : A27 - A27
  • [3] RADIOCHEMISTRY, BIOCHEMISTRY, AND KINETICS OF I-131 METAIODOBENZYLGUANIDINE (METAIODOBENZYLGUANIDINE) AND I-123 MIG - CLINICAL IMPLICATIONS OF THE USE OF I-123 METAIODOBENZYLGUANIDINE
    SHAPIRO, B
    GROSS, MD
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (04): : 170 - 177
  • [4] MYOCARDIAL IMAGING WITH I-123 METAIODOBENZYLGUANIDINE
    WALTON, S
    COSTA, DC
    ELL, PJ
    EMANUEL, RW
    [J]. BRITISH HEART JOURNAL, 1985, 54 (06): : 617 - 617
  • [5] SCINTIGRAPHY OF NEUROBLASTOMA WITH I-123 METAIODOBENZYLGUANIDINE
    FARAHATI, J
    KREMENS, B
    MULLER, SP
    SONNENSCHEIN, W
    REINERS, C
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P238 - P238
  • [6] COMPARATIVE-EVALUATION OF I-123 OCTREOTIDE (OCT) AND I-123 METAIODOBENZYLGUANIDINE (METAIODOBENZYLGUANIDINE) IN APUD-TUMORS
    WOLZT, M
    MEGHDADI, S
    KLETTER, K
    LEITHA, T
    ANGELBERGER, P
    SCHERNTHANER, G
    DUDCZAK, R
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1992, 19 (08): : 584 - 584
  • [7] KIT TYPE LABELING OF [I-123] METAIODOBENZYLGUANIDINE
    DOUGAN, H
    LYSTER, DM
    VINCENT, JS
    RIHELA, T
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1988, 25 (05): : 531 - 544
  • [8] COMPARISON OF MYOCARDIAL DISTRIBUTIONS BETWEEN I-123 BETAMETHYLIODOPHENYLPENTADECANOIC ACID (BMIPP) AND I-123 METAIODOBENZYLGUANIDINE (METAIODOBENZYLGUANIDINE) IN HYPERTROPHIC CARDIOMYOPATHY (HCM)
    HAMAMOTO, K
    TANADA, S
    HIGASHINO, H
    MURASE, K
    TSUDA, T
    SUGAWARA, Y
    INOUE, T
    KIMURA, Y
    HAMADA, M
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1992, 19 (08): : 664 - 664
  • [9] SECRETION OF [I-123] IODIDE IN BREAST-MILK FOLLOWING ADMINISTRATION OF [I-123] METAIODOBENZYLGUANIDINE
    KETTLE, AG
    ODOHERTY, MJ
    BLOWER, PJ
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1994, 21 (02): : 181 - 182
  • [10] I-123 METAIODOBENZYLGUANIDINE (I-123-METAIODOBENZYLGUANIDINE) AS AN INDEX OF NEURON INTEGRITY FOLLOWING MYOCARDIAL-INFARCTION
    SHEN, SW
    SISSON, JC
    SHULKIN, B
    FUNG, A
    SHAPIRO, B
    MEYERS, L
    ACKERMANN, R
    MALLETT, S
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (06) : 949 - 950